pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
Transforming growth factor-beta (TGF-beta) inhibits cell proliferation by inducing a G1-phase cell cycle arrest. Normal progression through G1 is promoted by the activity of the cyclin-dependent protein kinases CDK4 and CDK6 (ref. 2), which are inhibited by the protein p16INK4. We have isolated a new member of the p16INK4 family, p15INK4B. p15 expression is induced approximately 30-fold in human keratinocytes by treatment with TGF-beta, suggesting that p15 may act as an effector of TGF-beta-mediated cell cycle arrest. The gene encoding p15 is located on chromosome 9 adjacent to the p16 gene at a frequent site of chromosomal abnormality in human tumours (9p21).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to p16INK4A, p15INK4B has been shown to an effector of TGF-β meditated cell cycle arrest by inhibiting CDK4/6 (Hannon and Beach, 1994).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Hannon and Beach, 1994
In the citing paper
“Within months of its discovery, the INK4a (CDKN2A) and the genetically linked INK4b gene (CDKN2B) (36) were implicated in a reverse genetic screen to play tumor suppressive roles in familial melanoma (37).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [36]
Citations
Cites
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.
Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A., & Fusenig, N. E. (1988) · The Journal of cell biology · doi:10.1083/jcb.106.3.761 · Cited by 4,170
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
The Transforming Growth Factor-beta Family
Massague, J. (1990) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.06.110190.003121 · Cited by 3,015
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,043
Sherr, C. J. (1993) · Cell · doi:10.1016/0092-8674(93)90636-5 · Cited by 1,960
Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,954
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., & Carson, D. A. (1994) · Nature · doi:10.1038/368753a0 · Cited by 1,742
Research works printed but not linked: 7
- Bates, S. et al. Oncogene 9, 71–79 (1994).
- Merlo, A., Gabrielson, E., Askin, F. & Sidransky, D. Cancer Res. 54, 640–642 (1994).
- Cheng, J. Q., Jhanwar, S. C., Lu, Y. Y. & Testa, J. R. Cancer Res. 53, 4761–4763 (1993).
- Petty, E. M. et al. Am. J. hum. Genet. 53, 96–104 (1993).
- Moses, H. L. et al. in Cancer Cells (eds Feramisco, J., Ozanne, B. & Stiles, C.) 3, 65–71 (1985).
- Manning, A. M., Williams, A. C., Gamie, S. M. & Paraskeva, C. Oncogene 6, 1471–1476 (1991).
- Rodeck, U. et al. Cancer Res. 54, 575–581 (1994).
Cited by
Items 401–500 of 1,003
Increased Mitochondrial DNA Copy Number in Occupations Associated with Low-Dose Benzene Exposure
Carugno, M., Pesatori, A. C., Dioni, L., Hoxha, M., Bollati, V., Albetti, B., Byun, H.-M., Bonzini, M., Fustinoni, S., Cocco, P., et al. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1103979 · Cited by 113
Wahab, N. A., Weston, B. S., Roberts, T., & Mason, R. M. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000031828.58276.02 · Cited by 114
Xing, E. P., Nie, Y., Wang, L., Yang, G.-Y., & Yang, C. S. (1999) · Carcinogenesis · doi:10.1093/carcin/20.1.77 · Cited by 115
Dreßler, L., Bortolomeazzi, M., Keddar, M. R., Mišetić, H., Sartini, G., Acha‐Sagredo, A., Montorsi, L., Wijewardhane, N., Repana, D., Nulsen, J., et al. (2022) · Genome biology · doi:10.1186/s13059-022-02607-z · Cited by 131
“CSMD3 has a disputed cancer role [39–41] and a likely inflated mutation rate [42], while CDKN2B cooperates with its paralog CDKN2A to inhibit cell cycle [43], supporting its tumor suppressor role.”
BackgroundMcKarns, S. C., & Schwartz, R. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2071 · Cited by 113
The Cellular Effects of E2F Overexpression
Adams, P. D., & Kaelin, W. G. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-79910-5_4 · Cited by 132
Transforming Growth Factor-β Signaling in Epithelial Cells
Hartsough, M. T., & Mulder, K. M. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)00020-x · Cited by 136
Fåhræus, R., & Lane, D. P. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2106 · Cited by 125
“…p16INK4 family includes the closely related p15INK4b, p16INK4a, p18INK4c and p19INK4d proteins, which inhibit cdk4 and cdk6 kinase activities through direct interaction with the kinase subunit only (Serrano et al., 1993; Hannon and Beach, 1994; Chan et al., 1995; Hirai et al., 1995).”
BackgroundButz, H., Likó, I., Czirják, S., Igaz, P., Korbonits, M., Rácz, K., & Patócs, A. (2010) · Pituitary · doi:10.1007/s11102-010-0268-x · Cited by 124
Shintani, S., Nakahara, Y., Mihara, M., Ueyama, Y., & Matsumura, T. (2001) · Oral Oncology · doi:10.1016/s1368-8375(00)00142-1 · Cited by 118
Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation
Nakao, Y., Yang, X., Yokoyama, M., Ferenczy, A. S., Tang, S.-C., Pater, M. M., & Pater, A. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.243 · Cited by 123
Dao, M. A., Taylor, N. N., & Nolta, J. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13006 · Cited by 112
RhoA Stimulates p27Kip Degradation through Its Regulation of Cyclin E/CDK2 Activity
Hu, W., Bellone, C. J., & Baldassare, J. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.6.3396 · Cited by 112
p16INK4a and the control of cellular proliferative life span
Huschtscha, L. I. (1999) · Carcinogenesis · doi:10.1093/carcin/20.6.921 · Cited by 111
He, J., Tegen, S. B., Krawitz, A. R., Martin, G. S., & Luo, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304016200 · Cited by 124
Gorospe, M., Liu, Y., Xu, Q., Chrest, F. J., & Holbrook, N. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.762 · Cited by 111
Pawlyn, C., Bright, M. D., Buros, A. F., Epstein, J., Walters, Z. S., Aronson, L. I., Mirabella, F., Jones, J. R., Kaiser, M., Walker, B. A., et al. (2017) · Blood Cancer Journal · doi:10.1038/bcj.2017.27 · Cited by 119
Marra, D. E., Simoncini, T., & Liao, J. K. (2000) · Circulation · doi:10.1161/01.cir.102.17.2124 · Cited by 110
Human and Yeast Cdk-activating Kinases (CAKs) Display Distinct Substrate Specificities
Kaldis, P., Russo, A. A., Chou, H. S., Pavletich, N. P., & Solomon, M. J. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.9.2545 · Cited by 125
“…7, A and C, bottom panels). p16 and p18 had no effect on the phosphorylation of cdk2 by p40MO15 (Figure 7, B and D, bottom panels), reflecting the lack of binding of these proteins to cdk2 (Serrano et al., 1993; Guan et al., 1994; Hannon and Beach, 1994; Chan et al., 1995; Hirai et al., 1995).”
BackgroundInfluentialRoles of Smad3 in TGF-β Signaling During Carcinogenesis
Millet, C., & Zhang, Y. E. (2007) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v17.i4.30 · Cited by 133
Smad phosphoisoform signaling specificity: the right place at the right time
Matsuzaki, K. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr172 · Cited by 117
Radeke, M. J., Radeke, C. M., Shih, Y.-H., Hu, J., Bok, D., Johnson, L. V., & Coffey, P. J. (2015) · Genome Medicine · doi:10.1186/s13073-015-0183-x · Cited by 109
Park, B.-J., Park, J., Byun, D.-S., Park, J. H., & Chi, S. G. (2000) · PubMed · Cited by 127
Dichotomous roles of TGF-β in human cancer
Huang, J. J., & Blobe, G. C. (2016) · Biochemical Society Transactions · doi:10.1042/bst20160065 · Cited by 123
The INK4a/ARF locus in murine tumorigenesis
Serrano, M. (2000) · Carcinogenesis · doi:10.1093/carcin/21.5.865 · Cited by 108
Genetic abnormalities involved in the pathogenesis of gallbladder carcinoma
Wistuba, I. I., & Albores‐Saavedra, J. (1999) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s005340050113 · Cited by 107
Smad Transcriptional Corepressors in TGFβ Family Signaling
Wotton, D., & Massagué, J. (2001) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-10595-5_8 · Cited by 125
Kuan, C. J., al-Douahji, M., & Shankland, S. J. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v96986 · Cited by 107
Cheng, Y., Poulos, N. E., Lung, M. L., Hampton, G. M., Bao-xiang, O., Lerman, M. I., & Stanbridge, E. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3042 · Cited by 107
BF-1 Interferes with Transforming Growth Factor β Signaling by Associating with Smad Partners
Dou, C., Lee, J. H., Liu, B., Liu, F., Massagué, J., Xuan, S., & Lai, E. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.17.6201-6211.2000 · Cited by 123
A New Switch for TGFβ in Cancer
Yeh, H.-W., Lee, S.-S., Chang, C.-Y., Lang, Y.-D., & Jou, Y.-S. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2019 · Cited by 106
Shankland, S. J., Hugo, C., Coats, S. R., Nangaku, M., Pichler, R. H., GORDON, K. L., Pippin, J. W., Roberts, J. M., Couser, W. G., & Johnson, R. J. (1996) · Kidney International · doi:10.1038/ki.1996.432 · Cited by 106
The cell cycle regulator p27kip1 contributes to growth and differentiation of osteoblasts.
Drissi, H., Hushka, D. R., Aslam, F., Nguyen, Q., Buffone, E., Koff, A., van Wijnen, A. J., Lian, J. B., Stein, J. L., & Stein, G. S. (1999) · PubMed · Cited by 117
Genomic Alterations of the p19ARF Encoding Exons in T-Cell Acute Lymphoblastic Leukemia
Gardie, B., Cayuela, J.-M., Martini, S., & Sigaux, F. (1998) · Blood · doi:10.1182/blood.v91.3.1016 · Cited by 106
Significance of p16 in site-specific HPV positive and HPV negative HNSCC
Stephen, J. K., Divine, G., Chen, K. M., Chitale, D., Havard, S., & Worsham, M. J. (2012) · Cancer and Clinical Oncology · doi:10.5539/cco.v2n1p51 · Cited by 105
Sutherland, B. J. G., Koczka, K. W., Yasuike, M., Jantzen, S. G., Yazawa, R., Koop, B. F., & Jones, S. R. M. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-200 · Cited by 119
“cdkn2b induces cell cycle arrest in response to TGF-β [39].”
BackgroundDonovan, J. C. H., & Slingerland, J. M. (2000) · Breast Cancer Research · doi:10.1186/bcr43 · Cited by 129
Genetic and epigenetic changes in stomach cancer
Yokozaki, H., Yasui, W., & Tahara, E. (2001) · International review of cytology · doi:10.1016/s0074-7696(01)04003-7 · Cited by 112
Transforming Growth Factor-β Signal Transduction and Progressive Renal Disease 1
Cheng, J., & Grande, J. P. (2002) · Experimental Biology and Medicine · doi:10.1177/153537020222701102 · Cited by 117
Ogawa, S., Hangaishi, A., Miyawaki, S., Hirosawa, S., Miura, Y., Takeyama, K., Kamada, N., Ohtake, S., Uike, N., & Shimazaki, C. (1995) · Blood · doi:10.1182/blood.v86.4.1548.bloodjournal8641548 · Cited by 107
Defects in TGFβ signaling overcome senescence of mouse keratinocytes expressing v-rasHa
Tremain, R., Marko, M. G., Vijayachandra, K., Ueno, H., Böttinger, E. P., & Glick, A. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203471 · Cited by 112
Gene directed enzyme/prodrug therapy of cancer: Historical appraisal and future prospectives
Greco, O., & Dachs, G. U. (2001) · Journal of Cellular Physiology · doi:10.1002/1097-4652(2001)9999:9999<::aid-jcp1060>3.0.co;2-h · Cited by 273
Androgen Receptor Coregulators in Prostate Cancer
Rahman, M., Miyamoto, H., & Chang, C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0746-3 · Cited by 102
Zhu, H., Uusküla-Reimand, L., Isaev, K., Wadi, L., Alizada, A., Shuai, S., Huang, V., Aduluso-Nwaobasi, D., Paczkowska, M., Abd-Rabbo, D., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2019.12.027 · Cited by 101
Involvement of p21(WAF1/Cip1) and p27(Kip1) in intestinal epithelial cell differentiation
Tian, J. Q., & Quaroni, A. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.276.6.c1245 · Cited by 110
Concurrent Inactivation of RB1 and TP53 Pathways in Anaplastic Oligodendrogliomas
Watanabe, T., Yokoo, H., Yokoo, M., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.12.1181 · Cited by 102
Deletions and rearrangement of CDKN2 in lymphoid malignancy
Stranks, G., Height, S., Mitchell, P. L. R., Jadayel, D. M., Ma, Y., Lord, C., Clutterbuck, R. D., Treleaven, J., Powles, R. L., & Nacheva, E. P. (1995) · Blood · doi:10.1182/blood.v85.4.893.bloodjournal854893 · Cited by 107
Transforming growth factor-beta receptor type I gene is frequently mutated in ovarian carcinomas.
Chen, T., Triplett, J., Dehner, B., Hurst, B. M., Colligan, B. M., Pemberton, J. O., Graff, J. R., & Carter, J. H. (2001) · PubMed · Cited by 101
Alterations of the p15, p16, and p18 genes in osteosarcoma
Miller, C. W., Aslo, A., Campbell, M. J., Kawamata, N., Lampkin, B. C., & Koeffler, H. P. (1996) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(95)00216-2 · Cited by 116
Regulatory Role of p27kip1 in the Mouse and Human Testis
Beumer, T. L., Kiyokawa, H., Roepers‐Gajadien, H. L., van den Bos, L. A. C., Lock, T., Gademan, I. S., Rutgers, D. H., Koff, A., & de Rooij, D. G. (1999) · Endocrinology · doi:10.1210/en.140.4.1834 · Cited by 112
Differential CDK-inhibitor gene expression in aging human diploid fibroblasts
Wong, H., & Riabowol, K. T. (1996) · Experimental Gerontology · doi:10.1016/0531-5565(95)00025-9 · Cited by 114
Blokzijl, A., ten Dijke, P., & Ibáñez, C. F. (2002) · Current Biology · doi:10.1016/s0960-9822(01)00623-6 · Cited by 101
Hepatic senescence, the good and the bad
Huda, N., Liu, G., Hong, H., Yan, S., Khambu, B., & Yin, X.-M. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i34.5069 · Cited by 100
Dai, M., Al-Odaini, A. A., Fils-Aimé, N., Villatoro, M. A., Guo, J., Arakelian, A., Rabbani, S. A., Ali, S., & Lebrun, J. J. (2013) · Breast Cancer Research · doi:10.1186/bcr3441 · Cited by 100
Sakai, S., Ohhata, T., Kitagawa, K., Uchida, C., Aoshima, T., Niida, H., Suzuki, T., Inoue, Y., Miyazawa, K., & Kitagawa, M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3210 · Cited by 104
Identification of CDK4 Sequences Involved in Cyclin D1 and p16 Binding
Coleman, K. G., Wautlet, B. S., Morrissey, D., Mulheron, J., Sedman, S. A., Brinkley, P., Price, S., & Webster, K. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18869 · Cited by 100
Kudo, Y., Takata, T., Ogawa, I., Kaneda, T., Sato, S., Takekoshi, T., Zhao, M., Miyauchi, M., & Nikai, H. (2000) · PubMed · Cited by 108
Current Concepts in Neuro-Oncology: The Cell Cycle-A Review
Dirks, P. B., & Rutka, J. T. (1997) · Neurosurgery · doi:10.1097/00006123-199705000-00025 · Cited by 115
The Molecular Epidemiology of Lung Cancer
Spivack, S. D., Fasco, M. J., Walker, V. E., & Kaminsky, L. S. (1997) · Critical Reviews in Toxicology · doi:10.3109/10408449709089898 · Cited by 96
Ikushima, H., & Miyazono, K. (2011) · Cell and Tissue Research · doi:10.1007/s00441-011-1179-5 · Cited by 107
Bcr-Abl kinase down-regulates cyclin-dependent kinase inhibitor p27 in human and murine cell lines
Jonuleit, T., van der Kuip, H., Miething, C., Michels, H., Hallek, M., Duyster, J., & Aulitzky, W. E. (2000) · Blood · doi:10.1182/blood.v96.5.1933 · Cited by 99
Role of Cyclin-Dependent Kinases and Their Inhibitors in Cellular Differentiation and Development
Chellappan, S., Giordano, A., & Fisher, P. B. (1998) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-71941-7_4 · Cited by 102
Nagahara, H., Ezhevsky, S. A., Vocero-Akbani, A. M., Kaldis, P., Solomon, M. J., & Dowdy, S. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14961 · Cited by 112
Cell-cycle control and renal disease
Shankland, S. J. (1997) · Kidney International · doi:10.1038/ki.1997.335 · Cited by 103
Transforming growth factor‐β: The breaking open of a black box
Alevizopoulos, A., & Mermod, N. (1997) · BioEssays · doi:10.1002/bies.950190709 · Cited by 111
Intrinsic and acquired resistance to CDK4/6 inhibitors and potential overcoming strategies
Xu, X., Pan, X., Wang, T., Wang, J., Yang, B., He, Q., & Ding, L. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0416-4 · Cited by 111
Saltzman, A. G., Munro, R., Searfoss, G. H., Franks, C. F., Jaye, M., & Ivashchenko, Y. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4096 · Cited by 98
p57Kip2, a Glucocorticoid-Induced Inhibitor of Cell Cycle Progression in HeLa Cells
Samuelsson, M. K. R. (1999) · Molecular Endocrinology · doi:10.1210/me.13.11.1811 · Cited by 99
Liu, Y., Chen, L., Ko, T. C., Fields, A. P., & Thompson, E. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209403 · Cited by 107
“For example, in Mv1Lu cells TGFb-mediated growth arrest results from induction of p15INK4B (Hannon and Beach, 1994).”
BackgroundThe G protein‐coupled receptor kinase‐2 is a TGFβ‐inducible antagonist of TGFβ signal transduction
Ho, J., Cocolakis, E., Dumas, V. M., Posner, B. I., Laporte, S. A., & Lebrun, J. J. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600794 · Cited by 98
Yamagata, H., Matsuzaki, K., Mori, S., Yoshida, K., Tahashi, Y., Furukawa, F., Sekimoto, G., Watanabe, T., Uemura, Y., Sakaida, N., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.157.65.1 · Cited by 97
Vaccarino, F. M., Schwartz, M. L., Raballo, R., Rhee, J., & Lyn-Cook, R. (1999) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(08)60329-4 · Cited by 99
TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies
Sato, Y., Suto, Y., Pietenpol, J. A., Golub, T. R., Gilliland, D. G., Em, D., Beau, M. M. L., Roberts, J., Vogelstein, B., & Rowley, J. (1995) · Blood · doi:10.1182/blood.v86.4.1525.bloodjournal8641525 · Cited by 109
Datto, M., Hu, P. P.-C., Kowalik, T. F., Yingling, J. M., & Wang, X. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.2030 · Cited by 128
Sasaguri, T., Ishida, A., Kosaka, C., Nojima, H., & Ogata, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.8345 · Cited by 99
Zhang, X., Liu, D., Li, M., Cao, C., Wan, D., Xi, B., Li, W., Tan, J., Wang, J., Wu, Z., et al. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0400-8 · Cited by 101
Arresting developments in the cardiac myocyte cell cycle: Role of cyclin-dependent kinase inhibitors
Brooks, G., Poolman, R. A., & Li, J. M. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00125-4 · Cited by 113
Structure of the cyclin-dependent kinase inhibitor p19Ink4d
Luh, F. Y., Archer, S. J., Domaille, P. J., Smith, B. O., Owen, D., Brotherton, D. H., Raine, A. R. C., Xu, X., Brizuela, L., Brenner, S. L., et al. (1997) · Nature · doi:10.1038/40202 · Cited by 114
Chilosi, M., Doglioni, C., Yan, Z., Lestani, M., Menestrina, F., Sorio, C., Benedetti, A., Vinante, F., Pizzolo, G., & Inghirami, G. (1998) · Europe PMC (PubMed Central) · Cited by 96
Dowdy, S. C., Mariani, A., & Janknecht, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307202200 · Cited by 95
Tirado-Rodríguez, B., Ortega, E., Segura-Medina, P., & Huerta‐Yépez, S. (2014) · Journal of Immunology Research · doi:10.1155/2014/318481 · Cited by 116
Lee, D. K., Kim, B.-C., Kim, I. Y., Cho, E.-A., Satterwhite, D. J., & Kim, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206786200 · Cited by 103
Molecular foundations of cancer: New targets for intervention
Karp, J. E., & Broder, S. E. (1995) · Nature Medicine · doi:10.1038/nm0495-309 · Cited by 112
Alteration of p16 and p15 genes in human uterine tumours
Nakashima, R., Fujita, M., Enomoto, T., Haba, T., Yoshino, K., Wada, H., Kurachi, H., Sasaki, M., Wakasa, K., Inoue, M., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690379 · Cited by 105
“The p15 gene is induced by transforming growth fac (TGF-β), but the p16 gene is not (Hannon and Beach, 1994).”
BackgroundSiegel, P. M., Shu, W., & Massagué, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301413200 · Cited by 95
Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model.
Vijayachandra, K., Lee, J., & Glick, A. B. (2003) · PubMed · Cited by 113
Acute lymphoblastic leukemia in adolescents and young adults in Finland
Usvasalo, A., Räty, R., Knuutila, S., Vettenranta, K. K., Harila‐Saari, A. H., Jantunen, E., Kauppila, M., Koistinen, P., Parto, K., Riikonen, P. V., et al. (2008) · Haematologica · doi:10.3324/haematol.12466 · Cited by 98
CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas.
Hashemi, J., Platz, A., Ueno, T., Stierner, U. K., Ringborg, U. K., & Hansson, J. (2000) · PubMed · Cited by 95
Sakorafas, G. H., Tsiotou, A. G., & Tsiotos, G. G. (2000) · Cancer Treatment Reviews · doi:10.1053/ctrv.1999.0144 · Cited by 106
CDK2 Is a Target for Retinoic Acid-Mediated Growth Inhibition in MCF-7 Human Breast Cancer Cells
Teixeira, C., & Pratt, M. A. C. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.9.9977 · Cited by 100
Nip, J., Strom, D. K., Fee, B. E., Zambetti, G., Cleveland, J. L., & Hiebert, S. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1049 · Cited by 95
Zieske, J. D., Hutcheon, A. E. K., Guo, X. Q., Chung, E., & Joyce, N. C. (2001) · PubMed · Cited by 94
Role of Proteasomes in T Cell Activation and Proliferation
Wang, X., Luo, H., Chen, H., Duguid, W., & Wu, J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.788 · Cited by 94
Cytokines and tumors of the central nervous system
Meir, E. G. V. (1995) · Glia · doi:10.1002/glia.440150308 · Cited by 97
“…cell cycle; recent results show that it is mediated by TGFP induction of ~ 1 5 ' ~ and ~ 2 7 ' ~ , two cyclin cyclin-dependent kinase (CDK) complexes inhibitors (CKI), which prevent CDK-mediated retinoblastoma (Rb) phosphorylation and subsequent E2F-mediated S-phase entry (Hannon and Beach, 1994).”
BackgroundCayuela, J., Madani, A., Sanhes, L., Stern, M., & Sigaux, F. (1996) · Blood · doi:10.1182/blood.v87.6.2180.bloodjournal8762180 · Cited by 94
“(3) Hyperphosphorylated forms of Retinoblastoma gene protein product are found in T-ALL irrespective of the presence or absence of an intact copy of MTS2 (23 T-ALL cases tested; unpublished data).”
BackgroundMethodCDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma
McNeal, A. S., Liu, K., Nakhate, V., Natale, C. A., Duperret, E. K., Capell, B. C., Dentchev, T., Berger, S. L., Herlyn, M., Seykora, J. T., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0196 · Cited by 123
Islet biology, the CDKN2A/B locus and type 2 diabetes risk
Kong, Y., Sharma, R. B., Nwosu, B. U., & Alonso, L. C. (2016) · Diabetologia · doi:10.1007/s00125-016-3967-7 · Cited by 104
Bhaskaran, M., Kolliputi, N., Wang, Y., Gou, D., Chintagari, N. R., & Liu, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609060200 · Cited by 110
Matsuzaki, K., Date, M., Furukawa, F., Tahashi, Y., Matsushita, M., Sakitani, K., Yamashiki, N., Seki, T., Saito, H., Nishizawa, M., et al. (2000) · PubMed · Cited by 92
Somatic Acquisition and Signaling of TGFBR1 *6A in Cancer
Pasche, B., Knobloch, T. J., Bian, Y., Liu, J., Phukan, S., Rosman, D., Kaklamani, V., Baddi, L., Siddiqui, F., Frankel, W., et al. (2005) · JAMA · doi:10.1001/jama.294.13.1634 · Cited by 98
Metadata
- Authors
- Hannon, G. J., & Beach, D.
- Affiliations
- Howard Hughes Medical Institute (US)
- ORCID
- Hannon, Gregory J.
- Venue
- Nature
- Published
- 1994-09
- Volume
- 371
- Issue
- 6494
- Pages
- 257-261
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2003907692
- Cited by
- 1,950
- References
- 29
- Citations by year
- 2026: 14 · 2025: 11 · 2024: 26 · 2023: 26 · 2022: 22 · 2021: 30 · 2020: 18 · 2019: 42 · 2018: 29 · 2017: 24 · 2016: 37 · 2015: 48 · 2014: 37 · 2013: 44 · 2012: 54
- FWCI
- 51.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- CDKN2B, p16INK4, TGF-beta, cell cycle arrest, G1 phase, CDK4, CDK6, cyclin-dependent kinases, keratinocytes, 9p21, tumor suppressor, chromosome 9
- MeSH terms
- Amino Acid Sequence, Base Sequence, Carrier Proteins, Cell Cycle, Cell Line, Cloning, Molecular, Humans, Molecular Sequence Data, Proto-Oncogene Proteins, RNA, Messenger, Keratinocytes, Gene Expression, Transforming Growth Factor beta, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Cyclin-Dependent Kinases, Cyclin-Dependent Kinase Inhibitor p16, Tumor Suppressor Proteins, Cyclin-Dependent Kinase Inhibitor p15, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.